Unveiling New Horizons: AI in Medical Diagnosis for Global Expansion

Unveiling New Horizons: AI in Medical Diagnosis for Global Expansion

In the dynamic realm of healthcare, Artificial Intelligence (AI) has emerged as a revolutionary force, particularly in the domain of medical diagnosis. By combining the power of sophisticated algorithms with clinical insights, AI facilitates quicker and more accurate diagnostic processes, to the benefit of the patient, the practitioner and the whole healthcare chain alike. For companies with a visionary outlook, this presents a ripe opportunity to expand their horizons beyond domestic borders and thrive in the international arena.

 

The essence of this article lies in elucidating the transformative potential of AI in medical diagnostics, and how it can be a catalyst for companies aspiring for global expansion. As healthcare demands continue to escalate worldwide, leveraging AI can empower businesses to meet these challenges head-on, while adhering to the diverse and stringent regulatory landscapes of different regions – some of them often unfamiliar with the subject. Thus, delving into AI’s diagnostic prowess is not merely an exploration of technological advancement, but a voyage towards unlocking new avenues of growth and making impactful strides on the global healthcare stage.

Navigating the Transformation: Harnessing AI for Diagnostic Excellence

The journey of AI in reshaping the medical diagnostic landscape is nothing short of remarkable. Here’s a glance at the current impacted domains and the advantages AI beholds for businesses eyeing international expansion in the medical diagnosis field:

  • Early Detection and Diagnosis:

  • Improved Accuracy and Efficiency:

    • By reducing the scope of human error and solving multiple repeatability & consistency issues, AI enhances the accuracy of diagnoses.
    • It also expedites the diagnostic process, smoothening patient flow and ensuring timely intervention and better patient outcomes, as evidenced by a case where AI could diagnose heart conditions in just 15 seconds compared to the human average of 30 minutes to an hour​.
  • Potential Advantages for International Business Expansion:

    • Meeting Global Healthcare Standards: With AI, companies can elevate their diagnostic services to meet or even surpass international healthcare standards, a critical aspect for gaining a foothold in foreign markets in need for cutting-edge innovation.
    • Overcoming Geographical and Resource Constraints: Provided solutions are designed and implemented in conformity with relevant data safety and patient privacy regulations and standards, AI can help transcend geographical barriers and resource limitations by enabling remote diagnostics and optimizing resource utilization, making international expansion more feasible and sustainable.

The integration of AI in medical diagnostics not only sets the stage for enhanced healthcare delivery but also opens up a world of opportunities for companies to extend their services globally. By aligning with the global healthcare ethos of early and accurate diagnosis, companies can carve a niche for themselves in the international market, thereby achieving a significant competitive edge.

Regulatory and Ethical Landscape: Preparing for International Markets

Navigating through the diverse regulatory and ethical landscapes is a prerequisite for a successful foray into international markets with AI-driven medical diagnostics. Here are key considerations:

  • Understanding Diverse Regulatory Frameworks:

    • Familiarization with the regulatory requisites in target markets such as the US FDA’s framework or the EU’s Artificial Intelligence Act is imperative to ensure compliance and smooth market entry​. This is particularly true for expansion towards second-tier countries and territories where US or EU clearance is often a prerequisite to successful local registration, as is the case g. in China.
    • Engage with local regulatory bodies and seek local regulatory expert guidance to align your AI diagnostic solutions with the prevailing legal frameworks, particularly in terms of data safety, patient privacy, and cross-border data transfer and exploitation.
  • Ethical Considerations in AI-Driven Diagnostics:

    • Beyond strict regulatory and legal compliance, addressing ethical dilemmas such as privacy, bias, and transparency is vital to building trust with local stakeholders and patients.
    • Establish clear, documented ethical guidelines and ensure they are communicated across all levels of the organization.
  • Building Trust and Credibility:

    • Establishing a reputation for ethical practices and regulatory adherence can foster trust among patients, healthcare providers, and local authorities.
    • Develop a robust system for addressing grievances and ensuring accountability in AI-driven diagnostic processes.

Strategic Alliances: Fostering Global Partnerships

Forming strategic alliances is a cornerstone for successfully navigating the global landscape of AI in medical diagnostics. These partnerships can provide invaluable local insights and foster a conducive environment for growth and innovation. Here are some crucial steps and considerations:

  • Partnering with Local Healthcare Providers and Authorities:

    • Forge partnerships with local healthcare providers and authorities to better understand the local healthcare ecosystems, regulatory landscapes, and patient needs. Targeted adaptations in order to meet these needs can significantly enhance the local acceptance and impact of your AI-driven diagnostic solutions.
  • Engaging in Collaborative Research and Development:

    • Engage in collaborative research and development with local institutions, through ad hoc, publishable clinical research that allows practitioners to familiarize with your solutions, will help you innovate and refine AI diagnostic solutions in alignment with local healthcare challenges and global standards.
  • Case Examples of Successful International Expansions:

Conclusion: Seizing the Global Opportunity: Your Next Steps

The panorama of AI in medical diagnostics offers a fertile ground for companies aspiring to extend their outreach globally. By harnessing the transformative potential of AI, understanding diverse regulatory frameworks, contributing to the education of local regulatory bodies on your solutions‘ breakthroughs and advantages, forming strategic alliances, and learning from successful case examples, companies can navigate the complexities of international markets.

 

VVR Medical stands as a bridge for European medical technology and diagnostic innovators eyeing the expansive Chinese market, which uniquely combines a massive need for new diagnosis paradigms in order to cope with its widely-stretched healthcare challenges, a strong appeal for cutting-edge innovation, and a flexible regulator that is willing to interact with you at all stages of your development.

VVR Medical support

With a deep understanding of regulatory and market dynamics, as well as multiple successful cases, VVR Medical assists in navigating through the entry and establishment phases, ensuring a smoother transition into this promising market. The journey may pose challenges, yet the rewards of China expansion in this burgeoning field are promising. Now is the opportune time to strategize and embark on a venture that not only elevates healthcare standards worldwide but also propels your business to new heights on the international stage.

Read More
New Tech Applied in China’s Healthcare Industry

On 24 August, Irénée Robin, director and co-founder of VVR Medical, took part in the “New Tech Applied In China’s Healthcare Industry” round table organised by La French Tech Shanghai.

This article looks back at Irénée’s speech, during which he shared advice for medical technology companies wishing to succeed in the Chinese market. Passionate about the latest advances in the field, Irénée also spoke about recent innovations that have caught his attention, arousing fascination and hope, such as the use of virtual reality software to replace drugs in the treatment of central nervous system pathologies (such as pain or certain phobias)!

Irénée Robin began by sharing his expertise on the regulatory registration process for highly innovative products. He explained how to interact with the Chinese regulator (NMPA) when it comes to submitting marketing authorisation applications for technologies that are still unknown to them. In such cases, the procedures are long and complex, and the application for authorisation is not always validated, which is why it is advisable to enlist the help of an expert to maximise the chances of success.

Irénée Robin then insisted on the need to carry out an evaluation of his technology before initiating the registration procedures with a view to setting up a distribution network on the Chinese market. According to our expert, it is essential to test your product or service against a series of questions to determine whether it meets the needs of the Chinese medical sector and whether it is suitable for integration into the local market. Indeed, before taking the plunge, it is crucial to ensure that your product or service offers an improvement in solving a specific problem:

  • For patients (improved standard of care, diagnosis, prophylaxis, etc.)
  • For practitioners (facilitating or accelerating diagnosis, outpatient vs. inpatient care, clinical decision support, etc.)
  • For hospitals (lower costs, easier patient flow, synergies between departments, better use of local dispensaries or “points of care”, etc.)
  • To solve a major public health problem for the Chinese government (increase in home care, medico-economic impact, etc.).

In some cases, technology can provide solutions or improvements at different levels. For example, an innovation that makes it possible to diagnose certain illnesses at an early stage is a step forward for patients, as it means they can be treated less severely. It can also reduce the cost and duration of treatment for hospitals. Lastly, it can reduce the prevalence of certain diseases in the population, ultimately enabling the medical system to make savings on a national scale.

According to Irénée Robin, it is essential to be able to qualify and even measure precisely the impact that the product or service will have in solving the problem, and to identify who will benefit from this improvement. What’s more, it’s not just a question of introducing technology into healthcare to be considered a medical innovation. In fact, it is by combining technology, clinical skills and an understanding of care pathways (which are often complex and impossible to change in depth) that products and services acquire added value and revolutionise the medical sector. Medical innovation must meet the real expectations of patients and practitioners. Irénée Robin concluded by pointing out that the greatest successes in health tech are achieved by relying on multidisciplinary teams at every stage of research and development.

To sum up, before entering the Chinese market, you need to :

  1. Identify and qualify the precise improvement that the product or service will bring to the Chinese healthcare sector;
  2. Take account of the entire care chain and rely on an interdisciplinary team right from the development phase;
  3. Supporting innovation with knowledge of how the medical world works and the issues specific to the sector in China.

In the second part of his speech, Irénée Robin took a closer look at Franco-Chinese collaboration in the health tech sector. In his view, the best strategy for success in the Chinese market would be to retain all the research and development of product innovation in France, and to draw on the strengths of a Chinese partner to scale up and market innovations developed outside China throughout China. “The best alliances are those that play to the strengths of the partners, not those that aim to correct their weaknesses”.

Read More
How do you pay for your purchases when travelling in China? The guide, by VVR International

China leads the way in the use of electronic payments in Asia and worldwide

In China, the preferred method of payment has shifted from cash to mobile payment, to the detriment of credit cards. Indeed, China is now the world leader in the use of payment via mobile phone applications. Alipay and WeChat Pay are the main payment methods used by almost the entire Chinese population, whether urban or rural, and can be used to pay for fruit from a street vendor or to buy a plane ticket to Europe.

Electronic payment: essential for accessing certain applications and services

Cash payments are still accepted in theory, with the exception of orders and services linked to applications such as DIDI, a very widespread car-for-hire service in China, equivalent to Uber, or home catering services. These applications can only be paid for by electronic payment. You will therefore not be able to order a DIDI driver without first setting up an electronic payment solution. Note that DIDI can be used directly via Alipay and has an English interface, which is not the case for all applications. In fact, some applications such as Meituan and Ele.me, which sell takeaway food, are still only available in Chinese.

The decline in cash payments in all sectors of the Chinese economy

It should be noted, however, that the majority of vendors (taxi drivers, grocers, etc.) and businesses (restaurants and others, etc.) strongly prefer to be paid by Alipay and WeChat Pay rather than in cash.

In theory, international bankcards are accepted in shops, restaurants and hotels in major cities such as Shanghai, Beijing, Shenzhen and Guangzhou, but as terminals accepting international cards have been used very little or not at all over the last 3 years, this is no longer possible.

Electronic payment is now available to foreigners.

Historically, these 2 methods of payment were only available to holders of a bank card issued by a Chinese bank, which made travelling in China increasingly complex for non-resident foreigners.

To make your journey easier and ensure that you can make payments in all circumstances, it’s advisable to opt for one of the electronic payment options: WeChat Pay and Alipay.

Since August 2023, these methods have finally been accessible to foreigners who do not have a Chinese bank account! It is now possible to register for Alipay or WeChat Pay with :

  • a non-Chinese telephone number
  • foreign passport details
  • an international bank card

… Finally, create an Alipay and/or WeChat Pay account. Once you’ve done that, you can use these 2 applications for your everyday purchases.

The exchange rate applied to your transactions is set by the bank issuing your bank card. However, some functions, such as money transfers or red envelopes (an option for sending gifts to contacts, echoing the tradition of red envelopes given to children for the Chinese New Year), may not be accessible with a foreign bank card.

Before signing up for WeChat Pay and Alipay

  • Before registering for one of these applications, make sure that you are able to receive the verification codes by SMS that will be sent to you when you create your account (if not, you will need to obtain a Chinese SIM card).
  • It is possible to register from abroad, but identity verification must be carried out in China, as the face scan function is not available in some countries.

Practical installation guide : ALIPAY

  1. Download the application and sign up for the international version
  2. Add your bank account by pressing “add now”, then let the application guide you through the registration process.
  3. Scan the retailers’ QR codes or present your personal QR code to pay.

Practical installation guide : WECHATPAY

  1. Install WeChat on your phone (or make sure you have the latest version, update if necessary) then register with your phone number or log in.
  2. Activate Weixin Pay: to do this, click on “Me” – “Service” then “Wallet” in the application. You can also activate Weixin Pay by clicking on Me – settings – general – tools – weixin pay at the bottom of the screen.
  3. Enter your details and add a card by going to the Wallet tab and then pressing “add a card” to add your card. You will need to accept the terms of use and follow the steps to complete the identity details (if you are using a passport for this step, you will receive a notification prompting you to upload a copy of your ID to the app). Finally, press “Next” and follow the instructions in the application to add your card.
Read More
China, dream or real market opportunity for French startups?

Last 4th April 2023, on the occasion of the SNITEM Start-up day, Irénée Robin, founder and partner of VVR Medical, expert of Chinese health market, was with the MEDICALLIANS experts from UK – Germany – France – USA – Middle East, to present the development opportunities in the main international health markets.

During a workshop focusing on China, Irénée Robin, founder and partner of VVR Medical shared his vision of the Chinese healthcare market, and the business strategies for French companies.

Irénée Robin, founder and partner of VVR Medical shared his analysis

Irénée Robin, founder and partner of VVR Medical shared his analysis

Here are the key takeaways from his speech:

China is (still) striving for the world’s best & cheapest healthcare

The pandemic delayed the process and highlighted structural issues…

  • Suboptimal use of all components of the healthcare chain
  • Deficits in early diagnosis and treatment

…but has triggered changes providing new opportunities

  • Generalization of smart hospital systems
  • Clear vision of Big Data in healthcare

The triptych to achieve this objective in MedTech: Innovation, Scaleability, Affordability

  • Accelerated regulatory proceedings
  • Volume-Based Procurement
  • Promotion of local manufacturing

Those changes raise new questions and challenges for MedTech innovators

  • Market access, distribution channels
  • Realistic bottom line, value chain
  • IP protection, local partners

VVR Medical experts can help you !
Click here to contact Irénée Robin, Co-Founder & Managing Partner at VVR Medical, member of MEDICALLIANS.

Read More
PEO in China: Comparison with ASO, HRO, and How It Accelerates Business Expansion

PEO in ChinaComparison with ASO, HRO, and How It Accelerates Business Expansion

1. Introduction

For many foreign companies, entering the Chinese market means facing complex employment laws, high administrative costs, and long registration procedures. However, expansion no longer has to wait months for entity creation to occur. So, what is the solution? PEO in China, a flexible, compliant, and efficient HR model that lets companies hire staff and operate in China without establishing a local entity. In this article, VVR International provides a comprehensive comparison between PEO/EOR and ASO/HRO models, highlighting their key differences and strategic applications. You’ll also discover how PEO services in China can accelerate business expansion by combining compliance, flexibility, and cost efficiency, helping you determine which HR model best fits your company’s needs and growth objectives. 

2. What Is a PEO/EOR? Understanding the Model

A PEO (Professional Employer Organization) is a specialized HR partner that helps foreign companies hire employees in China while remaining compliant with Chinese labor laws. The PEO acts as a co-employer, managing HR administration, payroll, tax filings, and employment contracts, while the client company oversees day-to-day operations. This setup means you can operate in China without the need to establish a legal entity, while your employees receive full benefits and protection under local law. Moreover, working with a PEO/EOR offers: 

  • Hire and onboard employees in weeks, not months. 
  • Full alignment with Chinese labor, tax, and social insurance regulations. 
  • No need to register a Wholly Foreign-Owned Enterprise (WFOE). 
  • Local payroll, taxation, and health insurance managed seamlessly. 

A Professional Employer Organization (PEO) is not just a payroll service provider. It’s a long-term HR partner ensuring smooth operations for international companies in China. Specifically, in a PEO relationship: 

  • The client company manages the employee’s work and goals. 
  • The PEO/EOR organization in China becomes the local employer of record for HR, payroll, and compliance. 
  • The employee signs a compliant employment contract with the PEO/EOR but works directly under the client’s management. 

Essentially, PEO in China bridges the gap between global expansion and local compliance. It enables companies to enter the market quickly and legally. 

3. PEO in China vs Other HR Models

The HR landscape includes several models for managing employees abroad: PEO, ASO (Administrative Services Organization), and HRO (Human Resources Outsourcing). Each offers a different level of responsibility, cost, and control. Understanding their distinctions helps you choose the best fit for your company’s goals in China. 

Understanding the key differences

Understanding their distinctions helps you choose the best fit for your company’s goals in China.

Understanding their distinctions helps you choose the best fit for your company’s goals in China.

To help you choose the right option for your company, the following overview explains how PEO in China differs from ASO and HRO models in terms of control, compliance, and scalability. 

  • PEO: Co-employment model. The client and the Professional Employer Organization share employer responsibilities. 
  • ASO: Provides HR administration but doesn’t assume legal responsibility. 
  • HRO: Handles specific HR tasks like payroll, recruitment, or training, but only as a service provider. 

Table 1 below provides a side-by-side comparison of these four models. It outlines their core business factors, including structure, risk, scale, scope, cost, and services. Thus, you can quickly see which approach aligns with your expansion goals. 

Factor  PEO (Professional Employer Organization)  ASO (Administrative Services Organization)  HRO (Human Resources Outsourcing) 
Structure  Co-employment between client and PEO.  Client retains employer status; ASO provides admin support.  Client retains full control, outsources selected HR tasks. 
Risk  Shared compliance responsibility.  Client holds legal liability.  Client holds liability. 
Scale  Ideal for SMEs or mid-size firms expanding abroad.  Best for large firms with internal HR teams.  Best for large enterprises seeking efficiency. 
Scope  Covers employment, payroll, benefits, compliance.  Payroll and HR administration.  Training, recruitment, or HR consulting. 
Cost  Moderate, shared employment costs.  Lower, minimal HR services.  Variable depending on the services. 
Services  HR management, payroll, benefits and compliance.  Payroll and benefits admin.  Custom HR solutions. 

Table 1: Comparison Overview – PEO vs ASO and HRO 

PEO in China stands out for combining shared compliance, cost efficiency, and local HR expertise, making it an ideal option for businesses seeking flexibility without sacrificing control. 

While the first table compares strategic factors, the next one highlights practical HR features such as legal responsibility, compliance support, and payroll processing. You can use this snapshot to determine which model best meets your company’s operational and legal needs in China. 

Feature  PEO  ASO  HRO 
Is a legal entity needed?  No  Yes  Yes 
Serves as a legal employer?  Yes  No  No 
Shared legal liability?  Yes  No  No 
Offers compliance support?  Yes  Limited  Partial 
End-to-end HR services & payroll processing?  Yes  Yes  Depends on scope 
Talent staffing services?  Yes  Rarely  Occasionally 
Provision of employee payments?  Yes  Yes  Optional 

Table 2: Features at a glance – PEO vs ASO and HRO 

These key features demonstrate that the PEO model delivers the broadest HR coverage while minimizing legal risk and administrative work. For most foreign companies entering the Chinese market, partnering with a PEO in China provides the smoothest path to hiring, payroll management, and full compliance from day one. Understanding these distinctions is essential for choosing the most suitable HR framework for your business. The next section explains when to choose each model and why PEO in China often provides the perfect balance between agility, compliance, and operational control. 

When to choose each model 

Choosing the right HR model depends on your organization’s size, level of market commitment, and appetite for legal responsibility. Here’s when each approach makes sense and why PEO in China often strikes the best balance between cost efficiency, control, and compliance. 

  • PEO in China: Best when you want speed, compliance, and shared HR management without establishing a local entity. 
  • ASO: Works for larger companies that already have an entity but need help with payroll administration.
  • HRO: Established firms outsource specific HR functions or projects. 

For most international SMEs expanding into China, the PEO model offers the ideal balance between control, cost, and compliance. 

4. How PEO Services Accelerate Business Expansion in China

Expanding to China requires speed, local knowledge, and compliance with Chinese labor laws. A PEO in China acts as your local HR engine. It helps you hire employees, manage payroll, and operate legally, all within a matter of weeks. By partnering with a China PEO service, you can: 

  • Recruit and onboard staff quickly. 
  • Avoid costly delays in entity registration. 
  • Reduce legal risk through compliant HR management. 
  • Focus resources on business development instead of administration. 

The approach is particularly valuable for companies testing new markets, establishing representative offices, or running pilot projects before setting up a subsidiary. 

5. How PEO Services Work in China

VVR International signs a local employment contract with the employee, ensuring full compliance with Chinese labor laws.

VVR International signs a local employment contract with the employee, ensuring full compliance with Chinese labor laws.

PEO services in China follow a well-defined structure that simplifies every stage of employment: 

  • Employment contract setup: 
    • VVR International signs a local employment contract with the employee, ensuring full compliance with Chinese labor laws. 
    • The client company retains operational control while VVR manages administrative obligations.
  • Payroll management: 
    • VVR handles all salary calculations, bonuses, benefits, and health insurance contributions. 
    • Each month, the company receives one clear invoice covering gross salary, taxes, and service fees. 
  • Compliance and taxation: 
    • The PEO ensures compliance with local tax rules, including withholding tax and mandatory social contributions.
    • All payments are made to government-approved channels in the employee’s registered city.
  • HR and administrative support: 
    • VVR RH manages onboarding, probation, performance records, and offboarding in accordance with local law. 
    • For foreign employees, the company also handles work visa and residence permit applications.
  • Continuous legal assurance: 
    • With regular policy updates and proactive HR advice, PEO services maintain long-term compliance and transparency. 

With this structure, foreign companies can hire employees in China confidently, focusing on growth while the organization PEO in China handles the rest. 

6. Why Choose VVR RH as Your Best PEO Services Partner

When choosing a PEO service in China, experience, licensing, and local insight matter. VVR International stands out as a trusted partner combining European reliability with on-the-ground Franco-Chinese expertise. 

VVR International RH handles: 

  • Drafting legally compliant employment contract. 
  • Comprehensive HR management, including onboarding and employee relations. 
  • Full payroll administration (salary, benefits, bonuses, reimbursements). 
  • Administrative tasks such as social protection, housing fund, and health insurance. 
  • Taxation and withholding handled accurately each month. 
  • Contract renewals, terminations, and exit procedures. 
  • Immigration support for foreign employees (work visa and residence permit).
VVR RH stands out as a trusted partner combining European reliability with on-the-ground Franco-Chinese expertise.

VVR RH stands out as a trusted partner combining European reliability with on-the-ground Franco-Chinese expertise.

Operational highlights: 

  • Monthly invoicing for salaries and service fees ensures transparency. 
  • Holds an official Labor Dispatch License, authorizing legal employment of Chinese and foreign staff. 
  • Pays all taxes and social charges in the employee’s registered city, as required by law. 

Additional support from VVR RH: 

  • Intercultural management helps align European and Chinese work cultures for smoother onboarding. 
  • VVR’s teams in France and China coordinate time zones and expectations. 
  • Expatriate assistance offers adaptation training, relocation help, and ongoing HR support. 

More than HR outsourcing, we provide a complete ecosystem for your success in China, ensuring your team operates confidently and compliantly from day one. 


Read more related articles:


7. Final Thoughts

To sum up, a PEO in China allows businesses to hire, manage, and pay employees without setting up a local entity, combining compliance, speed, and scalability. Compared to other HR models, the PEO/EOR approach offers shared control, lower risk, and complete transparency. Whether you’re entering China for the first time or expanding your presence, partnering with an experienced provider like VVR International helps you navigate every step of your journey. 

Are you ready to start your expansion in China? Contact VVR International today to learn how our PEO services in China can help you hire employees, manage payroll, and stay compliant, without the burden of establishing a legal entity.

Share your project with us via contact@vvrinternational.com.

CONTACT US

FAQ

  • What are the main HR challenges in China that outsourcing helps foreign companies solve?

The main HR challenges in China include compliance with labor contract law, managing payroll across different cities, handling social insurance and housing fund contributions, and navigating work permit requirements for foreign employees.

HR outsourcing for foreign companies in China addresses these issues by providing local expertise, payroll outsourcing services, contract management under mutual agreement rules, and support for work permits. This allows companies to operate smoothly while minimizing legal and operational risks.

  • How do HR outsourcing services in China support strategic HR management and long-term growth?

HR outsourcing services in China support strategic HR management, aligning with modern HR practices in China, including digital HR solutions, employee retention strategies, and ESG-focused HR policies. By outsourcing HR functions, companies gain access to market insights, salary benchmarks, and compliance monitoring, enabling them to build sustainable teams in China while adapting to workforce trends and long-term business objectives.

Related Posts

Read More
Interview with Camille Verchery, in the newletter of the Club Chine de l’EM Lyon

Camille Verchery, Director and Founder of VVR International, discusses the strengths and dynamics of the Chinese market and highlights the opportunities for French companies in an interview with the Club Chine de l’EM Lyon.

ENERGY: AT THE HEART OF CHINA’S DEVELOPMENT STRATEGY

First and foremost, Energy has become a strategic sector for China in just a few years. Lacking fossil fuels, the country has invested heavily in research and development of alternatives to increase its independence from the rest of the world. As a result, China is now a leader in wind and photovoltaic energy, as well as nuclear power. It is also a major player in the battery industry and hydrogen technologies.

The challenge for French companies at the forefront of these fields will be to position themselves on the Chinese market, which is hungry for innovative technologies.

THE BOOMING CHINESE HEALTHCARE MARKET AND MEDICAL DEVICES

The Chinese healthcare market is extremely dynamic. Growth is driven by an aging population and increasing demand for healthcare services. China is keen to benefit from the excellence of foreign companies in this sector and is pursuing an attractive policy.

Finally, the introduction of social security as part of the government’s drive to improve the overall health of the population offers numerous development opportunities for innovative French healthcare and medical device companies.

START-UPS AND INNOVATION: CHINA AT THE FOREFRONT OF THE INTERNATIONAL SCENE

China has become one of the world’s leading incubators for start-ups. This success is driven by government funding and incentive policies that recognize the critical and strategic role of innovation in the international political and economic game.

In this context, the challenge is to identify the sectors in which France is a leader and to analyze Chinese advances in order to develop strategies that will enable French companies to benefit from them.

REGIONAL EXPERTISE FOR GLOBAL SUCCESS

Given the current market dynamics and challenges, the international development of companies is often destined to go beyond China. That’s why VVR International co-founded Globallians. Today, this network of partners brings together 16 international development support companies, each specializing in a particular region of the world.

By working together through the Globallians network, these companies are able to help companies expand internationally while providing the expertise needed to address the unique characteristics of each target region.

Read the full interview online on EM Lyon’s LinkedIn page, or click here to download the PDF.

Read More
Interview of Irénée Robin, Managing Partner at VVR Medical, on Radio Television HK

[PODCAST] Medical innovations in China Mainland and HK : The opportunities for foreign companies

Irénée Robin, Managing Partner at VVR Medical was present during the third Asia Summit on Global Health, in Hong Kong which brought stakeholders from healthcare experts to renowned academia and influential business leaders to explore opportunities in the healthcare sector.

Irénée Robin was one of the speakers at a session focused on medical technology at the event. On this occasion, he was invited by Radio Television Hong Kong for an interview about opportunities in the healthcare sector in Mainland China and HK.

 

You can listen to the replay of this interview by following this link:

First of all, how healthy would you say the level of investments into the healthcare industry in Mainland China is?

In Mainland China I tend to think that it’s never enough […] but it is increasing and it’s refocusing. The Chinese government has made the health of their own population a priority that they want to address with their own solutions. This strategy is leading to the integration of the whole manufacturing line of every medical device, product, medicine that is needed. In the healthcare sector, the cheapest consumable to the highest end implant tends to be made in China by China, for the Chinese people. This integration will actually generate affordability and eventually decrease the amount of investment or the amount of money needed to take care of the people.

These market dynamics are observable mainly in the day-to-day problems of healthcare in China, but not necessarily in Innovation scope.

About innovation, what are the sort of innovations you’re talking about here and where do we stand with those and what needs to happen to make those go ahead?

Over the past 20 years, China has been very good at scaling up and enabling as many people as possible to have access to basic healthcare. […] During the pandemic, especially the early stage, we saw a few of returnees having spent between 10 and 20 years in Europe or in the US, coming back to China to bring overseas innovation and trying to incubate it in China as well. Now the innovation mindset and spirit is strongly on the rise in China. A growing number of biotech and metric industries and companies are resolutely committed to innovation and introducing new technologies to the Chinese market. China’s gap in medical innovation is closing, but the challenge remains for foreign innovators wishing to penetrate the market. Indeed, this can prove difficult as the government focuses on mass production in China for the Chinese at the expense of innovative products which may not have the best commercial opportunities on the market […]. In this context, I work daily to find a way for the most innovative products to find their place on the Chinese market.

About some of these innovations, what are the most exciting developments that you’re keeping a watch on more broadly around medical technology […]?

Overall, everything related to AI and big data is at the forefront right now. But if we focus on China, […] big data innovations related to diagnosing diseases at an early stage are particularly interesting. A lot of China’s health problems could be solved by earlier diagnosis, but this is complicated by the sheer numbers of people and the way healthcare changes are organized, so the prospects for diagnostic innovations in the Chinese market are promising for years to come.

[…] You mentioned a lot about how China is very much focused on making things domestically and having them available domestically. Are there still opportunities for foreign enterprises to get involved in the sector?

A lot. […] For newcomers, if it’s a company offering an innovation that can solve a patient problem, a doctor problem, a problem related to hospital operations, or a problem related to health economics, or several of these problems at once, there’s a way forward. […] In addition, the legislation applicable in China may in some cases give an advantage to certain imported products: their registration may be faster than that of domestic products. Moreover, if products are registered as import devices, the company can make full use of its data abroad, including clinical data, which is not possible if the product is registered domestically.

Let’s take our attention now to Hong Kong and the greater Bay Area. […] What role do you think Hong Kong in the greater Bay Area can play in helping save the mainland companies’ expansion to a more global market?

Hong Kong has many roles to play for the medical industry. […] In terms of culture and relationships, Hong Kongese have a good understanding of the players and how the mainland market works. As a result, they are able to grasp the needs of Chinese companies wishing to go abroad. They can provide this cultural insight, but also in terms of investment capacity and the ability to mobilize local financial resources to ensure that these companies have a very strong and solid international arm.

 

You are interested in the opportunities offered by the Chinese Healthcare market? Irénée Robin and the dedicated team of VVR Medical experts can advise your company and help you realize your development project in China.

Contact us

Read More
Happy New Year of the Metal Ox!

VVR International team wish you all the best for this Chinese New Year of the Metal Ox!

Dear Friends, dear Partners,

According to the Chinese calendar, 2020 was the year of the Rat, as we have not lost our sense of humor, we will say that 2020 was the year of the Pangolin… or the year of the Bat…

Despite an unprecedented and difficult context, the year 2020 was for VVR International’s teams a symbol of solidarity, cohesion, resilience, recovery, and innovation.

We hope that 2021 will be synonymous of new projects, freedom, travel, and exchange.

Once again, an excellent year 2021 to all of you.

Read More
RAW MATERIALS INDEX RATE – MAY 2019

Here-under, the index rate of raw materials in China throughout the last 6 months.

Available in PDF : Download Newsletter VVR 2019 MAY

Read More
THE ROBOTICS EMPIRE

Subtitle

 

The seventh China Information Technology Expo took place between the 9 and the 11th of April 2019 in Shenzhen. In this event which gathered the World leaders of technologies, the visitors could discover and try the news and innovation like the Youxiaomei robot of the that served cups of tea. Although the exhibitors were from different nationalities, this event was a veritable vitrine for the Chinese progress in this sector.

According to the « made in China 2025 » which objective is to make China become a leader in the high-tech industry, investments are colossal in the Research and Development field. China would like to establish in the Global market of the innovation and strategic sectors. China has the ambition to export their technologies designed and developed nationally in order to put an end to their role of “world factory” that was occupied so far in the international trade. Thus, the high-tech is on the way to become the motor of the Chinese economy. The country counts the strongest growth of the world in the Robotics sector and would largely dominate it in the coming years. Even if the International Robotic Federation (IRF) pointed a delay for China in 2013 based on the number of robots per worker (25 units for 10 000 workers), the progresses were considerable as in 2016 it already counted, 68 robots for 10 000 workers. In 2018, 340 000 were employed in the Chinese factories. The number of companies which activity is linked to the robot construction is rising: in 2017, the country already counted more than 6500. But the Robotics field take off does not only concern Chinese companies, numerous foreign groups interested in the Robotic industry growth and the opportunities that offer the Chinese market set up their manufacturing workshops in China.

In the services sector, the Robotics field records in China the most important growth thanks to the Artificial Intelligence progresses and would represent a market of more than USD 2.9 billion by 2020. The strong enthusiasm of the companies for those technologies fulfils their will of performance and rentability also contributes to the sector dynamism.

Even though the robots are expensive to buy, they quickly permit to make significative cost reduction and improve efficiency. There are a lot of examples of uses in the services sector. The RobotHe restaurants of the Alibaba group only employ robots for the service permitting to increase the speed and save a considerable amount of money from employees. The robots are also used in the post services. Since 2016 they do the parcel sorting for one of the dominating mails operators of the country. In the distribution field, the e-commerce company JD.com significatively uses the robotization. It has warehouses all robotized. To deliver the orders, the company also uses robots, drones or autonomous vehicles. Thanks to those innovations, the group has improved its sales performances and delivering times. The robotization extends to the Health field. In some hospitals in Bejing or Shanghai, robots work at the reception desk: they have the capacity of answering thousands of questions and guide the patient to the required service. Operational since 2018, the robot developed by the Chinese group iFlytek is able to identify the diseases and realize the diagnosis. The education field gives way to the Robotics. In 2018, almost 600 nursery schools in China were using the teaching assistant Keeko developed to interact with pupils.

Finally, in the industry field, China is also leader in the Robotics market.  In 2016, the country represented 30% of it. The IRF plans that in 2020, China will use 950 300 robots in their factories and will produce 150000. The country is already a leader in the purchase and the use of robots and is about to lead the design and production.

From the daily life to the industry, the use of robots is massive. There would be approximately 3 million robots in the world in 2020 only in the industrial sector. The Chinese contribution to the development of robotics is huge. This increasing importance shows the change of the country position in the international market: once “workshop of the world”, it is today one of the leaders. The Chinese progress in the field of high technologies is living up to the desire of industrial development and the will of expend its influence in the key areas of the global economy.

Read More